BioPharm Asia, Inc (fka BFAR)

[wallas2g1]

The two issues you raise goes against the style of management of the company rather than the legitimacy of their business.
They do not seem to be investor friendly and are quite PR shy and that's what raises suspicions for most people.
I have no question as to the numbers they released yesterday or the legitimacy of their business.
No company that is doing shady business or doesn't exist will bother responding to the sec by filling their lease agreement or even bother with yesterday's release.
What I believe is happening is some kind of internal restructuring and/or just waiting for the auditors to clear the air before resuming other PR. Either way,IMO there is no need to call Missy since it is unlikely she'll answer any substantive questions about the business activities of BFAR (that's what PR releases are for).

While I understand your concerns with the sale of the subsidiary etc. I think it's just a matter of time before there's a PR about that too or the Chinese don't feel investors should know of a rescission of their decision to sell. My excuse for them is that this way of doing business is new to them. They'll soon learn to be a bit more transparent when they realise that's what investors feed on.

This is just my opinion and gut feeling about this co. Like I said before, I'm in till the end, bitter or sweet.